Consensus Stryker Corporation

Stocks

SYK

US8636671013

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 01:03:01 2026-10-28 pm EDT			5-day change	1st Jan Change
303.60 ^USD	+0.72%		+1.92%	-13.70%

10:18am	Evercore ISI Adjusts Stryker Price Target to $355 From $335	MT
Oct. 26	General Dynamics Awarded $135.9 Million Army Contract Modification	MT

Evolution of the Average Target: Stryker Corporation

Evolution of the Target Price: Stryker Corporation

Changes in Analyst Recommendations: Stryker Corporation

f96eb83.ppMMS_lkUoovmtqpPGsj5lDYPD1CW_v8ygOym9XJYC8._KJ9OrwKA95M-5fvZVgUrjS6RE4LP8KWgG7Z1738BE7-_TR8ihQYzmfggw~7150e1f25f34cf6b84098a0e204e5fd2

Analysts' recommendations: Stryker Corporation

10:18am	Evercore ISI Adjusts Stryker Price Target to $355 From $335	MT
Oct. 12	BTIG Adjusts Price Target on Stryker to $316 From $358	MT
Oct. 09	Leerink Partners Adjusts Stryker Price Target to $353 From $403	MT
Oct. 06	Truist Securities Cuts Stryker Price Target to $310 From $340, Maintains Hold Rating	MT
Oct. 06	Evercore ISI Adjusts Price Target on Stryker to $335 From $355, Keeps Outperform Rating	MT
Oct. 06	Evercore ISI Adjusts Stryker Price Target to $335 From $355, Maintains Outperform Rating	MT
Sep. 30	Stifel Adjusts Price Target on Stryker to $330 From $360, Maintains Buy Rating	MT
Sep. 22	TD Cowen Adjusts Price Target on Stryker to $298 From $355, Keeps Hold Rating	MT
Sep. 22	Jefferies Adjusts Price Target on Stryker to $405 From $440, Keeps Buy Rating	MT
Sep. 21	Raymond James Adjusts Price Target on Stryker to $330 From $370, Keeps Outperform Rating	MT
Sep. 18	Canaccord Genuity Adjusts Price Target on Stryker to $385 From $400, Keeps Buy Rating	MT
Sep. 17	Stryker Facing Promising Setup Next Year, Trading Upside Limited in 2026, RBC Says	MT
Sep. 14	Bernstein Adjusts Price Target on Stryker to $385 From $420, Keeps Outperform Rating	MT
Sep. 09	Citigroup Adjusts Stryker Price Target to $360 From $399, Maintains Buy Rating	MT
Sep. 09	Wells Fargo Adjusts Price Target on Stryker to $348 From $418, Keeps Overweight Rating	MT
Sep. 09	BMO Capital Adjusts Price Target on Stryker to $317 From $369, Keeps Outperform Rating	MT
Aug. 18	Leerink Partners Adjusts Price Target on Stryker to $403 From $407, Maintains Outperform Rating	MT
Aug. 13	Citigroup Adjusts Price Target on Stryker to $399 From $385, Maintains Buy Rating	MT
Aug. 05	Rothschild & Co Redburn Adjusts Stryker Price Target to $360 From $346	MT
Aug. 03	UBS Adjusts Stryker Price Target to $382 From $400, Maintains Buy Rating	MT
Aug. 03	Analyst recommendations: Chevron, Linde, RTX, Colgate-Palmolive, American Electric Power...
Jul. 31	RBC Cuts Price Target on Stryker to $420 From $435, Keeps Outperform Rating	MT
Jul. 31	Evercore ISI Adjusts Stryker Price Target to $355 From $350, Maintains Outperform Rating	MT
Jul. 31	Truist Lifts Price Target on Stryker to $340 From $330, Keeps Hold Rating	MT
Jul. 31	Raymond James Adjusts Price Target on Stryker to $370 From $383, Maintains Outperform Rating	MT

More recommendations

Medical Devices & Implants

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	STRYKER CORPORATION					+20.3%
	ABBOTT LABORATORIES					+14.96%
	MEDTRONIC PLC					+11.35%
	ESSILORLUXOTTICA					+18.76%
	CENCORA, INC.					+13.44%
	HOYA CORPORATION					+16.14%
	BECTON, DICKINSON AND COMPANY					+0.28%
	IDEXX LABORATORIES, INC.					+23.73%
	ALCON INC.					+30.6%
	DEXCOM, INC.					+22.44%
	Average					+17.20%
	Weighted average by Cap.					+16.09%